Respiratory syncytial virus renders dendritic cells tolerogenic

Details for Australian Patent Application No. 2009256014 (hide)

Owner Baylor Research Institute

Inventors Banchereau, Jacques F.; Connolly, John E.; Gill, Michelle A.

Agent Pizzeys

Pub. Number AU-A-2009256014

PCT Pub. Number WO2009/149397

Priority 61/059,650 06.06.08 US

Filing date 5 June 2009

Wipo publication date 10 December 2009

International Classifications

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

13 January 2011 PCT application entered the National Phase

  PCT publication WO2009/149397 Priority application(s): WO2009/149397

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009256015-Method and apparatus for directed device placement in the cerebral ventricles or other intracranial targets

2009256009-Methods for preparing 17-alkynyl-7-hydroxy steroids and related compounds